Fiorello Pharmaceuticals, Inc. — Form D

Fiorello Pharmaceuticals, Inc. of NEW YORK, NY, a company, filed a Form D exempt-offering notice with the SEC on 2015-06-17. The offering totals $2.5M, of which $2.5M was reported sold. Industry: Pharmaceuticals.

Offering

• Filed: 2015-06-17
• Form: D
• Accession: 0001642510-15-000001
• Industry: Pharmaceuticals
• Exemptions: 06b
• Total offering: $2.5M
• Amount sold: $2.5M
• Minimum investment: $50K
• Investors: 11
• Date of first sale: 2015-06-04
• Security types: equity
• Revenue range: Decline to Disclose
• SEC file number: 021-241956

Issuer

• Name: Fiorello Pharmaceuticals, Inc.
• CIK: 0001642510
• Entity type: Corporation
• Jurisdiction: NEW YORK
• Incorporated: 2014
• Address: 205 EAST 42ND STREET, 15TH FLOOR, NEW YORK, NY, 10017
• Phone: 917-687-6106

Officers, directors & promoters (2)

More

• CIK 1642510 on SEC EDGAR (source of record)
• This page as markdown (for LLM agents)
• Search all SEC filings, advisers and people on Adviser Search